Figure 1From: Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinibPC-9/GR exon 20 sequence. A. Wild type by direct sequencing. B. 3 of 20 clones had ACG > ATG T790M mutation by clone sequencing. C. 17 of 20 clones were wild typeBack to article page